Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Projecting a Per Share Price Target of $1.25, PotNetwork Holding Inc. Highlighted as “Strong Speculative Buy” in Research Initiated by Harbinger Research, LLC

Posted on: 09 Mar 18

FT LAUDERDALE, Fla., March 09, 2018 (GLOBE NEWSWIRE) -- PotNetwork Holding, Inc. (OTC Pink:POTN) (“Company”) is pleased to announce today that PotNetwork the Company and Diamond CBD have been the feature of a recent comprehensive research report projecting a price per share target of $1.25 by Harbinger Research, LLC, a notable equity research boutique based in Atlanta, Georgia.

To view the Harbinger Research Coverage Initiation report in its entirety visit:

Initiating coverage with a “Strong Speculative Buy” recommendation, Harbinger Research will be providing ongoing research on POTN over at least the next 12 months. Analyst Brian Connell, CFA, who covers the Company for Harbinger Research, stated "We are very pleased to have such a rapidly growing company with such a dynamic management team as part of our coverage universe. The cannabis industry is growing very rapidly, and we expect that this will continue for several years to come. As a first-mover and emerging market leader in many of its business lines, we believe this will clearly benefit PotNetwork Holding."

The report states: “PotNetwork Holding is an emerging market leader with in many cases first-mover advantage in its target markets.  As its sequential monthly revenue growth clearly shows, this Company has gotten it right.  It knows how to reach and sell to its target markets through a variety of online and brick-and-mortar channels, and its products are very well received by its distributors and retailers as well as by the consumers who use and enjoy them.” 

Brian R. Connell, CFA Senior Research Analyst, continued: “…we believe that POTN’s solid management team, ever-growing innovative product lines, and a very well executed sales and marketing strategy could very well be the key to becoming one of the sector’s first billion-dollar enterprises.” The study summarizes how Diamond CBD has focused on the development of a product line comprised of imported nature of hemp-derived cannabidiol (CBD) derivatives, which has lead to its phenomenal growth of legally acceptable CBD-containing products due to the changes in US Federal enforcement policies.

PotNetwork Holding Inc. recently announced that its wholly owned subsidiary, Diamond Inc., in just one and a half months into the year, reported that the Company had exceeded $3 Million in sales, and in February achieved over $500,000 in website-generated orders, surpassing all its previous online sales records.

About Diamond CBD Inc.: Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives.  Diamond CBD’s team consists of hemp industry pioneers and natural product experts, chemists, doctors and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils, tinctures, edibles, and vape liquids found anywhere. For more information, please visit its website at

About PotNetwork Inc.: PotNetwork Inc., a wholly owned subsidiary of the Company, brings to market, a counter-culture, cutting-edge digital magazine, publishing up-to-date news and articles on the cannabis industry. operates as a media resource providing a full range of industry related topics.

About PotNetwork Holding Inc:  PotNetwork Holding Inc. (OTC Pink:POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils.

Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.

Contact: PotNetwork Holding Inc. Investor Relations: Marisol Elwell, 1-800-915-3060


Last updated on: 12/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.